These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 22364647
41. Improvement and limitation of the reliability of automated QT measurement by recent algorithms. Tyl B, Azzam S, Blanco N, Wheeler W. J Electrocardiol; 2011; 44(3):320-5. PubMed ID: 21163494 [Abstract] [Full Text] [Related]
43. Heart rate dependence of the QT interval duration: differences among congenital long QT syndrome subtypes. Nemec J, Buncová M, Bůlková V, Hejlik J, Winter B, Shen WK, Ackerman MJ. J Cardiovasc Electrophysiol; 2004 May; 15(5):550-6. PubMed ID: 15149424 [Abstract] [Full Text] [Related]
44. The QT and corrected QT interval in recovery after exercise in children. Berger WR, Gow RM, Kamberi S, Cheung M, Smith KR, Davis AM. Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):448-55. PubMed ID: 21606386 [Abstract] [Full Text] [Related]
45. A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. Mansbach RS, Ludington E, Rogowski R, Kittrelle JP, Jochelson P. Clin Ther; 2011 Jul; 33(7):851-62. PubMed ID: 21722958 [Abstract] [Full Text] [Related]
46. An evaluation of ECG leads used to assess QT prolongation. Sadanaga T, Sadanaga F, Yao H, Fujishima M. Cardiology; 2006 Jul; 105(3):149-54. PubMed ID: 16449814 [Abstract] [Full Text] [Related]
47. Increased beat-to-beat QT variability in patients with congestive cardiac failure. Raghunandan DS, Desai N, Mallavarapu M, Berger RD, Yeragani VK. Indian Heart J; 2005 Jul; 57(2):138-42. PubMed ID: 16013353 [Abstract] [Full Text] [Related]
50. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation. Milic M, Bao X, Rizos D, Liu F, Ziegler MG. Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469 [Abstract] [Full Text] [Related]
53. Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs. Kligfield P, Badilini F, Denjoy I, Babaeizadeh S, Clark E, De Bie J, Devine B, Extramiana F, Generali G, Gregg R, Helfenbein E, Kors J, Leber R, Macfarlane P, Maison-Blanche P, Rowlandson I, Schmid R, Vaglio M, van Herpen G, Xue J, Young B, Green CL. Am Heart J; 2018 Jun; 200():1-10. PubMed ID: 29898835 [Abstract] [Full Text] [Related]
55. Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers. Luo WL, Crumley T, Ebel D, Atiee GJ, Royalty J, Johnson-Levonas AO, Wagner J, Lai E. J Clin Pharmacol; 2010 Nov; 50(11):1273-9. PubMed ID: 20107202 [Abstract] [Full Text] [Related]
56. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Charbit B, Alvarez JC, Dasque E, Abe E, Démolis JL, Funck-Brentano C. Anesthesiology; 2008 Aug; 109(2):206-12. PubMed ID: 18648229 [Abstract] [Full Text] [Related]